Evidence map›Paper›PMID 24566873›Full record

ArticleInflammation2014

Modulation of LPS-stimulated pulmonary inflammation by Borneol in murine acute lung injury model.

Weiting Zhong, Yiwen Cui, Qinlei Yu, Xianxing Xie, Yan Liu, Miaomiao Wei, Xinxin Ci, Liping Peng

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The Antibacterial and Anti-Inflammatory Potential ofPlants (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Anti-Inflammatory Effects ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  12. Structural characterization of borneol dehydrogenase from Pseudomonas sp. TCU-HL1.Acta crystallographica. Section F, Structural biology communications · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Analgesic-Like Activity of Essential Oil Constituents: An Update.International journal of molecular sciences · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Weiting ZhongDepartment of Respiration, the First Hospital of Jilin University, 71 Xinmin Road, Changchun, 130021, People's Republic of China.
Yiwen Cui
Qinlei Yu
Xianxing Xie
Yan Liu
Miaomiao Wei
Xinxin Ci
Liping Peng
Jilin University · CNFirst Hospital of Jilin University · CNInner Mongolia Comprehensive Disease Prevention and Control Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The object of our study is to investigate the protective effects of Borneol on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. To determine the effects of Borneol on the histopathological changes in mice with ALI, inflammatory cell count in bronchoalveolar lavage fluid (BALF) and lung wet/dry weight ratio were measured in LPS-challenged mice, and lung histopathologic changes observed via paraffin section were assessed. Next, cytokine production induced by LPS in BALF and RAW 264.7 cells was measured by enzyme-linked imunosorbent assay (ELISA). To further study the mechanism of Borneol-protective effects on ALI, nuclear factor-kappaB (NF-κB) and mitogen-activated protein kinases (MAPKs) pathways were investigated. In the present study, Borneol obviously alleviated pulmonary inflammation by reducing inflammatory infiltration, histopathological changes, descended cytokine production, and pulmonary edema initiated by LPS. Furthermore, Borneol significantly suppressed phosphorylation of NF-κB/P65, IκBa, p38, JNK, and ERK. Taken together, our results suggest that Borneol suppressed inflammatory responses in LPS-induced acute lung injury through inhibition of the NF-κB and MAPKs signaling pathways. Borneol may be a promising potential preventive agent for acute lung injury treatment.

Indexed as

Acute Lung InjuryAnimalsBronchoalveolar Lavage FluidCamphanesCell LineCell SurvivalDisease Models, AnimalDose-Response Relationship, DrugInterleukin-1betaInterleukin-6LipopolysaccharidesLungMAP Kinase Signaling SystemMiceNF-kappa BPneumoniaCamphanesInterleukin-1betaInterleukin-6interleukin-6, mouseisoborneolLipopolysaccharidesNF-kappa BTumor Necrosis Factor-alpha

Identifiers

PMID24566873
OpenAlexW1986406188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.